Scarica l'app Stockscreener
29.81
1.26%
0.37
Pre-mercato:
29.81
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Assembly Biosciences Inc Borsa (ASMB) Ultime notizie
Responsive Playbooks and the ASMB Inflection - Stock Traders Daily
EV Market: Is Assembly Biosciences Inc exposed to currency risks2026 Levels & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
ASMB Options Volatility — NASDAQ:ASMB - TradingView — Track All Markets
ASMB Options Chain — NASDAQ:ASMB - TradingView — Track All Markets
Weekly Earnings: Should I set a stop loss on Assembly Biosciences Inc2026 Intraday Action & Stock Portfolio Risk Control - baoquankhu1.vn
Sentiment Review: Is Assembly Biosciences Inc being accumulated by smart moneyQuarterly Investment Review & AI Driven Stock Reports - baoquankhu1.vn
ASMB Stock Price, Quote & Chart | ASSEMBLY BIOSCIENCES INC (NASDAQ:ASMB) - ChartMill
ASMB SEC FilingsAssembly Bioscie 10-K, 10-Q, 8-K Forms - Stock Titan
Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026 - Bitget
Assembly Bio's herpes drug studies win oral and late-breaker slots - Stock Titan
Treasury Yields: Will Assembly Biosciences Inc outperform during market ralliesWeekly Earnings Recap & High Win Rate Trade Tips - baoquankhu1.vn
Assembly Biosciences (ASMB) Gets a Buy from Guggenheim - The Globe and Mail
Fundamentals Check: Is Assembly Biosciences Inc stock showing strong momentumWeekly Gains Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Downgrade Watch: What is the target price for Assembly Biosciences Inc stock2026 Market Outlook & Consistent Profit Trade Alerts - baoquankhu1.vn
Options Flow: Is Assembly Biosciences Inc benefiting from innovation trends2026 Volume Leaders & Growth-Oriented Investment Plans - baoquankhu1.vn
Guggenheim Raises Price Target for ASMB to $43, Maintains Buy Ra - GuruFocus
Assembly Biosciences (NASDAQ:ASMB) Price Target Raised to $43.00 at Guggenheim - MarketBeat
Guggenheim raises Assembly Biosciences stock price target on herpes drug progress - Investing.com Canada
Understanding the Setup: (ASMB) and Scalable Risk - Stock Traders Daily
Bull Bear: What is the target price for Assembly Biosciences Inc stock2026 Retail Activity & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Assembly Biosciences CMO White sells $5.3k in stock By Investing.com - Investing.com Canada
Assembly Biosciences PFO Bjorkquist sells $8.7k in shares By Investing.com - Investing.com Australia
[Form 4] ASSEMBLY BIOSCIENCES, INC. Insider Trading Activity - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) officer logs RSU grant, tax sell-to-cover - Stock Titan
Assembly Biosciences (ASMB) officer awarded RSUs and sells shares to cover taxes - Stock Titan
Assembly Biosciences (ASMB) CMO awarded 26,000 RSUs vesting through 2030 - stocktitan.net
Assembly Biosciences (ASMB) CEO receives 94,250 RSUs vesting through 2030 - Stock Titan
Resistance Check: Is Assembly Biosciences Inc benefiting from innovation trends2026 WrapUp & Consistent Profit Trade Alerts - baoquankhu1.vn
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan - tipranks.com
Assembly Biosciences (ASMB) boosts CEO bonus target in 2026 plan - Stock Titan
HC Wainwright Analysts Lower Earnings Estimates for ASMB - Defense World
[EFFECT] ASSEMBLY BIOSCIENCES, INC. SEC Filing - Stock Titan
Wall Street Zen Upgrades Assembly Biosciences (NASDAQ:ASMB) to Strong-Buy - MarketBeat
ETF Watch: Is Assembly Biosciences Inc benefiting from innovation trends2026 Chart Watch & Advanced Technical Signal Analysis - baoquankhu1.vn
Q1 Earnings Estimate for ASMB Issued By HC Wainwright - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Receives "Buy" Rating from HC Wainwright - MarketBeat
Analyst Patrick R. Trucchio Reiterates Buy Rating for ASMB | ASM - GuruFocus
Highs Report: Is Assembly Biosciences Inc being accumulated by smart moneyOptions Play & Short-Term Trading Alerts - baoquankhu1.vn
Assembly Bio’s (ASMB) HBV Drug Shows Strong Efficacy in Phase 1b Trial - MSN
Assembly Biosciences (ASMB) Q4 earnings and revenues top estimates - MSN
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial - TipRanks
The Technical Signals Behind (ASMB) That Institutions Follow - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Upgraded at Wall Street Zen - MarketBeat
Assembly Biosciences (ASMB) Quarterly Profit Of US$22.1 Million Tests Bearish Narratives - simplywall.st
Assembly Biosciences: 'Buy' On HPI Program Opt-In And HDV Candidate Development (ASMB) - Seeking Alpha
Assembly Biosciences, Inc. 2025 Annual Report – Pipeline, Risk Factors, and Financial Outlook - Minichart
Assembly Biosciences Inc (V7B.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Assembly Biosciences (NASDAQ:ASMB) Announces Quarterly Earnings Results, Beats Estimates By $2.99 EPS - MarketBeat
Assembly Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates - Yahoo Finance
Assembly Biosciences Q4 Earnings: Profit Announced, Annual Loss NarrowsNews and Statistics - IndexBox
Assembly Biosciences (ASMB) launches $100M ATM via Jefferies under $400M shelf - Stock Titan
Assembly Biosciences: Fourth Quarter Financial Results Overview - Bitget
Assembly Biosciences: Q4 Earnings Snapshot - MarketScreener
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights - The Manila Times
Assembly Biosciences 2025 net loss narrows - tradingview.com
Assembly Biosciences (NASDAQ: ASMB) advances antiviral pipeline and expands Gilead deal - Stock Titan
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):